Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase EARLY_PHASE1 1Phase 1 1

Status

Recruiting 5Completed 4Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Thoracic 5Myeloid 2Other solid neoplasm 1

Conditions

Breast Neoplasms 539Neoplasms 482Carcinoma, Non-Small-Cell Lung 395Prostatic Neoplasms 314Colorectal Neoplasms 300Lung Neoplasms 265Neoplasm Metastasis 222Ovarian Neoplasms 199Leukemia, Myeloid, Acute 197Pancreatic Neoplasms 187Multiple Myeloma 174Recurrence 135Squamous Cell Carcinoma of Head and Neck 133Stomach Neoplasms 131Brain Neoplasms 131Melanoma 127Carcinoma, Hepatocellular 126Glioblastoma 121Endometrial Neoplasms 121Triple Negative Breast Neoplasms 113Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Hematologic Neoplasms 104Head and Neck Neoplasms 100Carcinoma, Renal Cell 98Lymphoma 96Urinary Bladder Neoplasms 93Sarcoma 91Glioma 88Rectal Neoplasms 83Small Cell Lung Carcinoma 82

Interventions

sugemalimab 1aldesleukin 1Pharmaceutical Preparations 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Pleural Effusion, Malignant × 90 days × Clear all
NCT07636252 2026-06-09

EX VIVO DRUG RESPONSE PROFILING AND OUTCOME PREDICTION IN LUNG ADENOCARCINOMA

Sheba Medical Center

Recruiting
400 enrolled
MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Adenocarcinoma of Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT06097962 2026-05-20

Safety and Efficacy of NK510 to Treat NSCLC

Base Therapeutics (Shanghai) Co., Ltd.

Phase EARLY_PHASE1 Recruiting
12 enrolled
Thoracic

Pleural Effusion, Malignant

NCT07332858 2026-05-15

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

China-Japan Friendship Hospital

Phase 1/2 Recruiting
105 enrolled
MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT05543330 2026-05-14

A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC

Wuhan YZY Biopharma Co., Ltd.

Phase 1/2 Recruiting
96 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡